Menu
NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
7475 Lusk Blvd
San Diego, California 92121-5707
Phone: 18589091800
www.nuvasive.com
WASHINGTON (dpa-AFX) - NuVasive, Inc. (NUVA) announced it received 510(k) clearance from the FDA for the use of its Precice all-internal limb lengthening solution to include pediatric patients. Pr…
https://www.investing.com/news/assorted/nuvasive-received-510k-clearance-from-fda-for-the-use-of-its-precice-allinternal-limb-lengthening-solution-to-include-pediatric-patients-432SI-3034515
SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will participate in upcoming…
https://www.investing.com/news/pro/nuvasive-pt-raised-to-53-at-barclays-432SI-3013603
https://www.investing.com/news/pro/nuvasive-pt-raised-to-45-at-jpmorgan-432SI-3012020
https://www.investing.com/news/pro/nuvasive-pt-lowered-to-45-at-baird-432SI-3011883
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ETCompany ParticipantsJuliet Cunningham - VP, IRChristopher Barry - CEO & DirectorMatthew…
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: $24.08 million in Q4 vs. -$36.74 million in the same period last year. EPS: $0.42 in Q4 vs. -$0.71 in t…
NuVasive press release (NUVA): Q4 Non-GAAP EPS of $0.43 misses by $0.08.Revenue of $305.4M (+1.1% Y/Y) misses by $5.61M.The Company expects 2023 net sales growth of 6%ꟷ8% on an…
Full-year 2022 net sales grew 5.5% as reported, 8.5% on a constant currency basis Continued strong international growth in 2022 U.S. cervical delivers growth of greater than 20% year-over-year driven by C360 2,000+ Pulse cases performed worldwide since commercial launch …
https://www.investing.com/news/assorted/nuvasive-enhances-c360-portfolio-with-expanded-indications-for-modulus-cervical-and-attrax-putty-432SI-3008947
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered…
NuVasive Inc. (NASDAQ:NUVA) shares, rose in value on Friday, 02/10/23, with the stock price down by -5.79% to the previous day’s close as strong demand from buyers drove the stock to $44.40. Actively observing the price movement in the last trading, the stock closed the session at $47.13, falling within a range of $43.54 and … NuVasive Inc. (NASDAQ: NUVA) Forecast: Expect A -41.89% Drop Within A Few Months Read More »
Technical analysis of these three Hot stocks (NUVA, SCHW, XPO) NuVasive, Inc. a USA based Medical Devices Company, belongs to a Healthcare Sector. The Charles Schwab Corporation a USA based … The post Enslaving stocks: NuVasive, Inc. (NASDAQ:NUVA -5.79%), The Charles Schwab Corporation (NYSE:SCHW 1.11%), XPO Logistics, Inc. (NYSE:XPO -6.92%) appeared first on Stocks Equity .
Globus Medical fell 3.4% on Friday after plunging 18% on Thursday after the announcement of an all-stock acquisition of NuVasive, prompting a slew of Wall Street…
https://www.investing.com/news/pro/nuvasive-pt-raised-to-47-at-baird-432SI-3000532
https://www.investing.com/news/pro/truist-securities-downgrades-nuvasive-to-hold-432SI-3000210
https://www.investing.com/news/pro/citi-downgrades-nuvasive-to-neutral-432SI-3000204
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Beguiling stocks: NuVasive, Inc. (NASDAQ:NUVA 2.95%), ChargePoint Holdings, Inc. (NYSE:CHPT -2.63%) appeared first on Stocks Equity .
NuVasive (NUVA) could see another bidder come in over the top after agreeing to an all-stock sale to Globus Medical (GMED), according a Truist analyst
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Intraday Alert: NuVasive, Inc. (NASDAQ:NUVA 5.72%), Cybin Inc. (AMEX:CYBN -0.67%) appeared first on Stocks Equity .
